Rapid SARS-CoV-2 antigen detection by immunofluorescence – a new tool to detect infectivity
Abstract
The evaluated SARS-CoV-2 antigen rapid fluorescence immunoassays reliably identified patients within the first 5 days of symptom onset, when respiratory secretions carried high viral loads. This high performance suggests that these tests might play an important role for future PCR-independent strategies to detect early or infective cases.
Related articles
Related articles are currently not available for this article.